Mar 27 |
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
|
Feb 10 |
Sonoma Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
Feb 8 |
Sonoma Pharmaceuticals GAAP EPS of -$0.08 beats by $0.13, revenue of $3.14M misses by $0.62M
|
Feb 8 |
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
|
Jan 23 |
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use
|
Jan 9 |
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
|
Dec 14 |
Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
|
Dec 8 |
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
|
Nov 14 |
Sonoma Pharmaceuticals GAAP EPS of -$0.29 misses by $0.05, revenue of $2.73M misses by $0.75M
|
Nov 13 |
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results
|